Dietary lipids and multiple sclerosis.
The epidemiological and biochemical evidence supporting a role of dietary lipids in Multiple Sclerosis is reviewed. The published controlled trials of omega six Polyunsaturated Fatty Acids including 172 patients with Acute Remitting Multiple Sclerosis are discussed and the results of recent study with omega three Polyunsaturated Fatty Acids in a Double Blind controlled study involving 312 patients are presented. It appears that there is a trend suggesting that the addition of omega six and omega three Polyunsaturated Fatty Acids to the diet of patients with Multiple Sclerosis results in a reduction of the severity and frequency of relapses and in a mild overall benefit in a two year period.
Bates
D
D
Department of Neurology, University of Newcastle upon Tyne, UK.
D004042:Dietary Fats, Unsaturated / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006801:Humans; D009103:Multiple Sclerosis / Q000178:diet therapy* / Q000453:epidemiology
D004042:Dietary Fats, Unsaturated; D015525:Fatty Acids, Omega-3